Navigation Links

Thymocytes are T cell precursors which develop in the thymus. The processes of beta-selection, positive selection and negative selection shape thymocytes into a peripheral pool of T cells that are able to respond to foreign pathogens and are immunologically tolerant towards self antigens.


Stages of maturation

Thymocytes are classified into a number of distinct maturational stages based on the expression of cell surface markers. The earliest thymocyte stage is the double negative stage (negative for both CD4 and CD8), which more recently has been better described as Lineage-negative, and which can be divided into four substages. The next major stage is the double positive stage (positive for both CD4 and CD8). The final stage in maturation is the single positive stage (positive for either CD4 or CD8).

Stage Defining surface markers Location Significant events
Double negative 1 or ETP (Early T lineage Progenitor) Lineage-CD44+CD25-CD117+ cortex -
Double negative 2 Lineage-CD44+CD25+CD117+ cortex -
Double negative 3 Lineage-CD44-CD25+ cortex TCR beta rearrangement
Double negative 4 Lineage-CD44-CD25- cortex -
Double positive CD4+CD8+ cortex Positive selection, negative selection
Single positive CD4+CD8- or CD4-CD8+ medulla Negative selection, regulatory T cell conversion

Events during maturation

type: functional (beta selection) functional (positive selection) autoreactive (negative selection)
location: cortex cortex cortex/medulla

In order to pass the beta-selection point, the beta chain of the T cell receptor rearranged by the thymocyte must retain the structural properties allowing it to be presented on the surface of the thymocyte with pre-TCRalpha. This eliminates thymocytes with gross defects introduced into the T cell receptor by gene rearrangement.

In order to be positively-selected, thymocytes will have to interact with several cell surface molecules, MHC/HLA, to ensure reactivity and specificity.[1]

Positive selection selects cells with a T cell receptor able to bind MHC class I/II or peptide molecules with at least a weak affinity. This eliminates (by a process called "death by neglect") those T cells which would be non-functional due to an inability to bind MHC.

Negative selection is the active induction of apoptosis in thymocytes with a high affinity for self peptides or MHC. This eliminates cells which would direct immune responses towards self-proteins in the periphery. Negative selection is not 100% complete, some autoreactive T cells escape thymic censorship, and are released into the circulation.

Additional mechanisms of tolerance active in the periphery exist to silence these cells such as anergy, deletion, and regulatory T cells. If these peripheral tolerance mechanisms also fail, autoimmunity may arise.

Thymus Settling

Thymocytes are ultimately derived from bone marrow hematopoietic progenitors cells [see hematopoietic stem cell, hematopoiesis] which reach the thymus through the circulation.[2] The number of progenitors that enter the thymus each day is thought to be extremely small. Therefore which progenitors colonize the thymus is unknown. Currently Early Lymphoid Progenitors (ELP) are proposed to settle the thymus and are likely the precursors of most thymocytes. ELPs are Lineage-CD44+CD25-CD117+ and thus closely resemble ETPs, the earliest progenitors in the thymus. Precursors enter the thymus at the cortico-medullary junction. Molecules known to be important for thymus entry include CD44, P-selectin (CD62P), and the chemokine receptor CCR9.[3]

Following thymus entry, progenitors proliferate to generate the ETP population. This step is following by the generation of DN2 thymocytes which migrate from the cortico-medullary junction toward the thymus capsule. DN3 thymocytes are generated at the subcapsular zone and undergo beta selection.

Beta selection

Histology of the thymus showing the cortex and medulla
Minute structure of thymus.

The ability of T cells to recognise foreign antigens is mediated by the T cell receptor, which is a surface protein able to recognise short protein sequences (peptides) that are presented on MHC. During the double negative stage the major maturation step of thymocytes is to express a T cell receptor.

Unlike most genes, which have a stable sequence in each cell which expresses them, the T cell receptor is made up of a series of alternative gene fragments. In order to create a functional T cell receptor, the double negative thymocytes use a series of DNA-interacting enzymes to clip the DNA and bring separate gene fragments together. The outcome of this process is that each T cell receptor has a different sequence, due to different choice of gene fragments and the errors introduced during the cutting and joining process. The evolutionary advantage in having a large number of unique T cell receptors is that each T cell is capable of recognising a different peptide, providing a defence against rapidly evolving pathogens.[4].

The cellular disadvantage in the rearrangement process is that many of the combinations of the T cell receptor gene fragments are non-functional. To eliminate thymocytes which have made a non-functional T cell receptor, the beta-selection point is required before T cells can advance from the double negative to the double positive stage. The beta-selection point requires that the first T cell receptor gene to be arranged (T cell receptor beta) is capable to binding a pre-T cell receptor alpha protein and assembling on the surface with the signalling proteins. Thymocytes which fail this "beta selection" die by apoptosis.

Positive selection and lineage commitment

Thymocytes which pass "beta selection" express a T cell receptor which is capable of assembling on the surface. However many of these T cell receptors will still be non-functional, due to an inability to bind MHC. The next major stage of thymocyte development is positive selection, to keep only those thymocytes which have a T cell receptor capable of binding MHC. The T cell receptor requires CD8 as a coreceptor to bind to MHC class I, and CD4 as a coreceptor to bind MHC class II. At this stage thymocytes upregulate both CD4 and CD8, becoming double positive cells.

Double positive thymocytes that have a T cell receptor capable of binding MHC class I or class II with even a weak affinity receive signalling through the T cell receptor.[5]. Thymocytes that have a T cell receptor incapable of binding MHC class I or class II undergo apoptosis. Some thymocytes are able to rescue failed positive selection by receptor editing (rearrangement of the other T cell receptor allele to produce a new T cell receptor).

The double positive thymocytes undergo lineage commitment, maturing into a CD8+ T cell (recognising MHC class I) or a CD4+ T cell (recognising MHC class II). Lineage commitment occurs at the late stage of positive selection and works by downregulation of both CD4 and CD8 (reducing the signal from the T cell receptor) and then upregulation of CD4 only. Thymocytes that start receiving signal again are those that recognise MHC class II, and they become CD4+ T cells. Thymocytes that do not start receiving signal again are those that recognise MHC class I, and they downregulation CD4 and upregulate CD8, to become CD8+ T cells. Both of these thymocytes types are known as single positive thymocytes.

Negative selection

Success in positive selection allows the thymocyte to undergo a number of maturational changes during the transition to a single positive T cell. The single positive T cells upregulate the chemokine receptor CCR7, causing migration from the cortex to the medulla. At this stage the key maturation process involves negative selection, the elimination of autoreactive thymocytes.

The key disadvantage in a gene rearrangement process for T cell receptors is that by random chance, some arrangements of gene fragments will create a T cell receptor capable of binding self-peptides presented on MHC class I or MHC class II. If T cells bearing these T cell receptors were to enter the periphery, they would be capable of activating an immune response against self, resulting in autoimmunity. Negative selection is the process evolved to reduce this risk. During negative selection, all thymocytes with a high affinity for binding self peptides presented on MHC class I or class II are induced to upregulate Bim, a protein which drives apoptosis. Cells which do not have a high affinity for self ('safe' cells) survive negative selection.

Negative selection can occur at the double positive stage in the cortex. However the repertoire of peptides in the cortex is limited to those expressed by epithelial cells, and double positive cells are poor at undergoing negative selection. Therefore the most important site for negative selection is the medulla, once cells are at the single positive stage. In order to remove thymocytes reactive to peripheral organs, the gene AIRE drives the expression of multiple peripheral antigens, such as insulin, creating an "immunological self-shadow".[6][7] This allows single positive thymocytes to be exposed to a more complex set of self-antigens than is present in the cortex, and therefore more efficiently deletes those T cells which are autoreactive.

Single positive thymocytes remain in the medulla for 1-2 weeks, surveying self-antigens to test for autoreactivity. During this time they undergo final maturational changes, and then exit the thymus using S1P and CCR7. Upon entry to the peripheral bloodstream, the cells are considered mature T cells, and not thymocytes.


Thymocytes that gain oncogenic mutations allowing uncontrolled proliferation can become thymic lymphomas.

Alternative lineages

As well as classical T cells, a number of alternative cell lineages develop in the thymus, including gamma-delta T cells, Natural Killer T cells and lymphoid dendritic cells.


  1. ^ Baldwin TA, Hogquist KA, Jameson SC, The fourth way? Harnessing aggressive tendencies in the thymus. “J Immunol.” 173:6515-20, 2004.]
  2. ^ Schwarz BA, Bhandoola A. Trafficking from the bone marrow to the thymus: a prerequisite for thymopoiesis. Immunol Rev 209:47, 2006. full text
  3. ^ Schwarz BA, Sambandam A, Maillard I, Harman BC, Love PE, Bhandoola A. Selective thymus settling regulated by cytokine and chemokine receptors. J Immunol. 2007 Feb 15;178(4):2008-17.]
  4. ^ Sleckman BP, Lymphocyte antigen receptor gene assembly: multiple layers of regulation. Immunol Res 32:153-8, 2005. full text
  5. ^ Baldwin TA, Hogquist KA, Jameson SC, The fourth way? Harnessing aggressive tendencies in the thymus. “J Immunol.” 173:6515-20, 2004.]
  6. ^ Anderson, M.S. et al. (2002) Projection of an Immunological Self-Shadow Within the Thymus by the Aire Protein. Science 298 (5597), 1395-1401
  7. ^ Liston, A. et al. (2003) Aire regulates negative selection of organ-specific T cells. Nat Immunol 4 (4), 350-354


(Date:10/6/2015)... ... October 06, 2015 , ... (Portland, Ore.) — Researchers at ... be administered orally in a single pill. , The compound is based on a ... in the Journal of Medicinal Chemistry, show that the compound cures malaria in a ...
(Date:10/6/2015)... ... , ... "When I was on crutches, I was unable to walk to the living room ... Mo. "I live alone, so I had nobody around to help me. This inspired me ... , He created a prototype for the BUTLER to enable an individual on crutches to ...
(Date:10/6/2015)... (PRWEB) , ... October 06, 2015 , ... He suits ... shift. He loves his work, which he takes very seriously. And he’s ... is a three-year old German shepherd, chocolate lab and golden retriever mix, who works ...
(Date:10/6/2015)... ... October 06, 2015 , ... Dr. Castellano’s book “ We Guarantee We Can Make You ... of Amazon’s main list and on the top 10 in its non-fiction list, where it ... on Friday and #2 on the non-fiction list. , During the week of September 13-19, ...
(Date:10/6/2015)... ... October 06, 2015 , ... Are you looking for an effective way to ... FOOT MASSAGE provides a massaging and therapeutic workout for the feet. In doing so, ... The invention features an effective design that is convenient and easy to use. It ...
Breaking Medicine News(10 mins):Health News:Portland State Researchers Discover Possible One-Pill Cure For Malaria 2Health News:Man’s (And Woman’s) Best Friend at Monarch Landing 2Health News:Man’s (And Woman’s) Best Friend at Monarch Landing 3Health News:Man’s (And Woman’s) Best Friend at Monarch Landing 4Health News:Dr. Rich “The Smile Dr.” Castellano lands on the Wall Street Journal Best-Seller List 2Health News:Modified Foot Massager Invented by InventHelp Client (IPL-209) 2
... YORK, Pa., March 9 The Danone Baby Nutrition ... bottle manufacturing plant in Zoetermeer, the Netherlands, as the ... is the equivalent of a supplier-of-the-year award and is ... at all levels -- during 2008," said Rafael Fernandez, ...
... monitoring for chronically ill patients will soon become a ... devised a decentralized system to avoid medical data overload. ... of the International Journal of Computer Applications in ... illnesses, including diabetes, high blood pressure, and heart problems ...
... (NYSE Alternext US: CVM) announced today that it ... Byron Biopharma ("Byron") under which CEL-SCI has granted ... the Company,s cancer drug Multikine(R) in the Republic ... has existing licensing agreements for Multikine with Teva ...
... with National Osteoporosis FoundationCHICAGO, March 9 Dental ... recent news reports about how osteoporosis medications might ... to help them separate fact from fiction. The ... Osteoporosis Foundation to create the brochure, "Osteoporosis Medications ...
... are skipping medical, dental visits because of financial concerns ... three-quarters of adult Americans who have health insurance say ... care, and nearly 50 percent say they,re "very" or ... Interactive/HealthDay poll shows. , More than half (57 ...
... today announced that it has raised over $20 million ... Company raised approximately $15 million through equity contributions by ... Focus, Intel Capital, Saudi Venture Development Company, Unilever Technology ... participated as a new investor. On top of ...
Cached Medicine News:Health News:Graham Packaging On-Site Plant in Zoetermeer Wins Top Performance Award From The Danone Baby Nutrition and Medical Nutrition Divisions 2Health News:Peer-to-peer heart monitoring 2Health News:CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa 2Health News:ADA Informs Patients About Osteoporosis Medications and Oral Health 2Health News:ADA Informs Patients About Osteoporosis Medications and Oral Health 3Health News:Most Insured Adults Worry About Health Care Costs: Poll 2Health News:Most Insured Adults Worry About Health Care Costs: Poll 3Health News:Most Insured Adults Worry About Health Care Costs: Poll 4Health News:Surface Logix Raises $20 Million in Financing and Starts Phase 2b Clinical Trial of SLx-4090 in Dyslipidemia and Diabetes 2
Other medicine definitionOther Tags